Skip to content

Resistance following failure of injectable cabotegravir/rilpivirine may limit future treatment options

Second Berlin patient has unusual immune response that seems to have removed his HIV

Hepatitis B reactivation is rare after switching from tenofovir, two European studies show

New European HIV guidelines address sleep, obesity and breastfeeding

Three ways Ukraine is using AI to improve HIV services

Tailored cancer screening strategies needed for people with HIV

Too few people with HIV receiving statins despite guideline changes

Less weight gain with Dovato than Biktarvy

STIs and doxyPEP at EACS: community effectiveness, gonorrhoea resistance and ‘blunted’ syphilis

Increased STI diagnoses in gay men with HIV are mainly due to more testing

Chemsex use is changing in Europe

Antibody from Tanzanian woman suppresses almost all tested HIV variants including resistant viruses in pre-clinical study

Huge disparities in PrEP uptake across Europe – injectable PrEP largely inaccessible

How Europe's busiest PrEP clinics are simplifying care and reaching new populations

Higher education increased HIV risk in Africa then became protective

Gender-focused training for HIV providers reduces stigma but implementation proves challenging

Integrase inhibitors reduce heart risks in people with HIV in the US

Scale-up of online HIV and STI self-sampling hasn’t led to more equitable outcomes in England